|
ZNF836 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.59380000003462E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.69939999997248E-06 |
| Normal-vs-Stage2 |
1.941610E-03 |
| Normal-vs-Stage3 |
8.09260000000922E-05 |
| Normal-vs-Stage4 |
4.565900E-04 |
| Stage1-vs-Stage2 |
9.195200E-01 |
| Stage1-vs-Stage3 |
3.026800E-01 |
| Stage1-vs-Stage4 |
2.015600E-01 |
| Stage2-vs-Stage3 |
5.187200E-01 |
| Stage2-vs-Stage4 |
2.741000E-01 |
| Stage3-vs-Stage4 |
5.886200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.95645999999661E-05 |
| Normal-vs-AfricanAmerican |
1.224940E-04 |
| Normal-vs-Asian |
1.411840E-02 |
| Caucasian-vs-AfricanAmerican |
8.937600E-01 |
| Caucasian-vs-Asian |
5.224200E-01 |
| AfricanAmerican-vs-Asian |
5.399600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.18360000268237E-08 |
| Normal-vs-Female |
1.323510E-02 |
| Male-vs-Female |
3.370300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.395100E-04 |
| Normal-vs-Extreme_Weight |
1.08920000019275E-07 |
| Normal-vs-Obese |
4.257400E-03 |
| Normal-vs-Extreme_Obese |
8.434700E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.209400E-01 |
| Normal_Weight-vs-Obese |
2.181200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.186800E-01 |
| Extreme_Weight-vs-Obese |
7.541500E-03 |
| Extreme_Weight-vs-Extreme_Obese |
5.435400E-01 |
| Obese-vs-Extreme_Obese |
7.010100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.364700E-03 |
| Normal-vs-Age(41-60Yrs) |
2.103400E-03 |
| Normal-vs-Age(61-80Yrs) |
1.2285999995143E-07 |
| Normal-vs-Age(81-100Yrs) |
9.996200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.302800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.127600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.195200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.710240E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.461020E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.482000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.0297000000189E-06 |
| Normal-VS-Type2 PRCC |
1.9825999730827E-09 |
| Normal-VS-KIRP CIMP |
1.714400E-02 |
| Normal-VS-Unclassified PRCC |
6.863600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.414700E-04 |
| Type1 PRCC-VS-KIRP CIMP |
5.536800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.093800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.535200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.155870E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.806400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.6032999995459E-07 |
| Normal-vs-N1 |
3.342200E-03 |
| Normal-vs-N2 |
1.1030000000023E-06 |
| N0-vs-N1 |
2.636200E-01 |
| N0-vs-N2 |
1.486400E-01 |
| N1-vs-N2 |
1.082490E-02 |
|
|
